RTW Biotech Opportunities Ltd
RTWFF
$2.00
$0.073.63%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -9.99% | -9.99% | 936.90% | 936.90% | 132.83% |
| Total Revenue | -9.99% | -9.99% | 936.90% | 936.90% | 132.83% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -9.99% | -9.99% | 936.90% | 936.90% | 132.83% |
| SG&A Expenses | -2.47% | -2.47% | 19.12% | 19.12% | 79.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.24% | 3.24% | 23.88% | 23.88% | 82.26% |
| Operating Income | -55.82% | -55.82% | 972.22% | 972.22% | 2.19% |
| Income Before Tax | 653.64% | 653.64% | -147.46% | -147.46% | -201.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 653.64% | 653.64% | -147.46% | -147.46% | -201.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 653.64% | 653.64% | -147.46% | -147.46% | -201.86% |
| EBIT | -55.82% | -55.82% | 972.22% | 972.22% | 2.19% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 669.57% | 669.57% | -148.28% | -148.28% | -163.87% |
| Normalized Basic EPS | 377.27% | 377.27% | -77.59% | -77.59% | -30.18% |
| EPS Diluted | 669.57% | 669.57% | -148.28% | -148.28% | -163.87% |
| Normalized Diluted EPS | 377.27% | 377.27% | -77.59% | -77.59% | -30.18% |
| Average Basic Shares Outstanding | -2.78% | -2.78% | -1.68% | -1.68% | 59.38% |
| Average Diluted Shares Outstanding | -2.78% | -2.78% | -1.68% | -1.68% | 59.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |